The Additional Advantages of 99Tcm-MIBI SPECT/CT Imaging in Hyperparathyroidism

HAN Jiangqin, DAI Na, ZHANG Bin, DONG Jiajia, LIU Hang

PDF(1631 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1631 KB)
Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (7) : 1236-1241. DOI: 10.11748/bjmy.issn.1006-1703.2024.07.012
Clinical Investigation

The Additional Advantages of 99Tcm-MIBI SPECT/CT Imaging in Hyperparathyroidism

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(7): 1236-1241 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.07.012

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1631 KB)

Accesses

Citation

Detail

Sections
Recommended

/